Green PolkaDot Box Granted License for Exclusive U.S. Virtual Club Market Rights to Greenleaf Medical’s New Ingredient, Appethyl(R)

MOUNT PLEASANT, Utah, June 24, 2014 (GLOBE NEWSWIRE) Green PolkaDot Box Incorporated (OTC:GPDB) GPDB announced today that it has entered into an agreement with Greenleaf Medical for an exclusive license to use the intellectual property pertaining to and the ingredient known as Appethyl® in the U.S. virtual club market for humans and in the ecommerce channel on a non-exclusive basis. We are thrilled to be selected by Greenleaf Medical as one of its few partners in the U.S. for distribution of a breakthrough product that we estimate will have broad appeal to potentially millions of consumers seeking the benefits of acute and long-term appetite suppression, says GPDB CEO Rod Smith. We anticipate that Appethyl® will become a major revenue generator, a gateway product, a potential flagship product, that can attract consumers who are seeking a healthier dietary lifestyle to Green PolkaDot Box. Appethyl® is a unique formula that is based on an extract from spinach components—thylakoids
http://bit.ly/1jL73E2